When it comes to assessing patients with suspected pulmonary embolism, contrast-enhanced CT pulmonary angiography has no diagnostic edge over a certain free-breathing, unenhanced MRI perfusion protocol.

Experts recently compared the use of a 0.55T low-field MRI system to a 1.5T system to determine whether the results rendered were within an acceptable diagnostic range.

There are a number of well-intended recommendations for preventing MRI injuries, but many of them stop short of implementing safety requirements.

For patients with anxiety and depression, even mild cases of long COVID could result in functional and structural alterations of the brain.

New data out of the University of New Mexico suggest that the imaging agent’s physiologic reach may exceed what was previously believed.

A new study utilizing multi-organ MRI scans recently identified organ impairment in 62% of COVID long haulers six months after their initial diagnosis; 29% of these individuals continued to display damage in at least one organ at the 12-month mark.

A new paper in the European Journal of Radiology offers an updated overview of common MRI findings in patients who develop foot drop following total hip arthroplasty.

A Feb. 14 announcement from Bracco indicates that the recently FDA-approved, gadolinium-based contrast agent VUEWAY, also known as gadopiclenol, is officially being used for patients undergoing MR imaging.